- Home
- MRVI vs MIY Comparison
MRVI vs MIY Comparison
Compare MRVI & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- MIY
- Stock Information
- Founded
- MRVI 2014
- MIY 1992
- Country
- MRVI United States
- MIY United States
- Employees
- MRVI N/A
- MIY N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- MIY Investment Bankers/Brokers/Service
- Sector
- MRVI Health Care
- MIY Finance
- Exchange
- MRVI Nasdaq
- MIY Nasdaq
- Market Cap
- MRVI 312.4M
- MIY 324.7M
- IPO Year
- MRVI 2020
- MIY N/A
- Fundamental
- Price
- MRVI $2.22
- MIY $11.25
- Analyst Decision
- MRVI Hold
- MIY
- Analyst Count
- MRVI 10
- MIY 0
- Target Price
- MRVI $6.84
- MIY N/A
- AVG Volume (30 Days)
- MRVI 1.9M
- MIY 56.8K
- Earning Date
- MRVI 05-12-2025
- MIY 01-01-0001
- Dividend Yield
- MRVI N/A
- MIY 3.98%
- EPS Growth
- MRVI N/A
- MIY N/A
- EPS
- MRVI N/A
- MIY N/A
- Revenue
- MRVI $241,856,000.00
- MIY N/A
- Revenue This Year
- MRVI N/A
- MIY N/A
- Revenue Next Year
- MRVI $10.73
- MIY N/A
- P/E Ratio
- MRVI N/A
- MIY N/A
- Revenue Growth
- MRVI N/A
- MIY N/A
- 52 Week Low
- MRVI $1.67
- MIY $9.45
- 52 Week High
- MRVI $10.03
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- MRVI 52.01
- MIY 41.49
- Support Level
- MRVI $2.20
- MIY $10.84
- Resistance Level
- MRVI $2.41
- MIY $11.44
- Average True Range (ATR)
- MRVI 0.15
- MIY 0.19
- MACD
- MRVI 0.01
- MIY -0.03
- Stochastic Oscillator
- MRVI 58.06
- MIY 50.62
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.